news

友邦保险集团近日投资120.33亿元认购中邮人寿24.99%投资后股权。君合律师事务所、德普律师事务所为友邦保险提供法律意见;高伟绅律师事务所则担任中邮人寿律师。

中邮人寿成立于2009年,总部位于北京,是中国邮政旗下国有全资寿险公司,专注于提供财务保障服务。友邦保险成立于1919年,总部位于中国香港,2010年在港交所上市。此次增资成功后,友邦保险将成为中邮人寿第二大股东。

高伟绅团队由合伙人方刘、廖宇飞律师牵头领导。

CC, Debevoise lead on China Post Life’s 24.99% stake sale to AIA for $1.86 bln

Clifford Chance has advised China Post Life on the sale of a 24.99 percent stake for $1.86 billion to AIA Group Limited, which was advised by Debvoise Plimpton and Jun He.

Established in 2009, the Beijing-headquartered China Post Life is a subsidiary of China Post Group. It is a bank-affiliated life insurer providing financial protection in China. The Hong Kong-headquartered and listed AIA was established in 1919. Following the stake sale, AIA will become the second largest shareholder of China Post Life.

The Clifford Chance team was led by partners Fang Liu and Liao Yufei.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

华润饮料拟赴港上市(ZH/EN)

by Charlie Wu 吴卓言 |

华润饮料(控股)有限公司(华润饮料)已于4月22日向香港联合交易所递交上市申请。自2022年以来,华润饮料几度被传筹备推动华润饮料赴港上市,据彭博报道,该项目募资规模或达 10 亿美元。

竞天公诚、金杜等助力茶百道登陆香港联交所(ZH/EN)

by Charlie Wu 吴卓言 |

4月23日,四川百茶百道实业股份有限公司(茶百道)在香港联合交易所主板挂牌上市,募资额达3.3亿美元。

高伟绅、司力达牵头赛生药业11.3亿美元私有化交易(ZH/EN)

近日,私募股权公司德福资本对港交所上市公司赛生药业提出私有化邀约。本次私有化交易通过协议安排方式实施,实施所需的现金总额约为 87.9 亿港元(约 为11.3 亿美元)。